Go Pro

Exponent (NASDAQ:EXPO) CEO Sells $113,139.96 in Stock

Exponent logo with Industrials background
Image from MarketBeat Media, LLC.

Key Points

  • CEO Catherine Corrigan sold 1,707 Exponent shares for $113,139.96 under a pre-arranged Rule 10b5-1 plan, reducing her holdings by 1.3% to 129,108 shares.
  • Exponent reported quarterly earnings of $0.60 per share, surpassing the $0.55 analyst estimate, while revenue rose 12% year over year to $171.61 million.
  • Shares recently traded at $67.51, while analysts maintain a “Moderate Buy” consensus with an average price target of $81. The company also declared a quarterly dividend of $0.31 per share, yielding about 1.8%.
  • MarketBeat previews top five stocks to own in September.

Exponent, Inc. (NASDAQ:EXPO - Get Free Report) CEO Catherine Corrigan sold 1,707 shares of the company's stock in a transaction on Monday, August 17th. The shares were sold at an average price of $66.28, for a total value of $113,139.96. Following the sale, the chief executive officer owned 129,108 shares of the company's stock, valued at approximately $8,557,278.24. This trade represents a 1.30% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Catherine Corrigan also recently made the following trade(s):

  • On Monday, June 15th, Catherine Corrigan sold 4,119 shares of Exponent stock. The stock was sold at an average price of $57.13, for a total value of $235,318.47.

Exponent Stock Up 2.0%

Shares of Exponent stock traded up $1.32 during trading hours on Tuesday, reaching $67.51. 380,459 shares of the stock traded hands, compared to its average volume of 537,623. The company has a 50 day moving average price of $62.15 and a 200 day moving average price of $64.59. The firm has a market capitalization of $3.21 billion, a price-to-earnings ratio of 30.27 and a beta of 0.68. Exponent, Inc. has a one year low of $51.91 and a one year high of $81.95.

Exponent (NASDAQ:EXPO - Get Free Report) last released its quarterly earnings results on Thursday, July 30th. The business services provider reported $0.60 EPS for the quarter, beating the consensus estimate of $0.55 by $0.05. The firm had revenue of $171.61 million during the quarter, compared to analyst estimates of $144.99 million. Exponent had a net margin of 17.67% and a return on equity of 31.48%. The business's revenue for the quarter was up 12.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.52 EPS. Sell-side analysts anticipate that Exponent, Inc. will post 2.31 earnings per share for the current year.

Exponent Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 18th. Shareholders of record on Friday, September 4th will be issued a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date of this dividend is Friday, September 4th. Exponent's dividend payout ratio is currently 55.61%.

Analyst Ratings Changes

EXPO has been the topic of several analyst reports. UBS Group set a $72.00 price target on shares of Exponent and gave the stock a "neutral" rating in a research note on Friday, July 31st. Weiss Ratings reaffirmed a "hold (c-)" rating on shares of Exponent in a report on Friday, July 17th. Finally, JPMorgan Chase & Co. lifted their target price on Exponent from $80.00 to $90.00 and gave the company an "overweight" rating in a research report on Friday, July 31st. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $81.00.

Get Our Latest Stock Analysis on EXPO

Institutional Investors Weigh In On Exponent

Several hedge funds and other institutional investors have recently added to or reduced their stakes in EXPO. Bell Investment Advisors Inc lifted its holdings in Exponent by 423.6% during the first quarter. Bell Investment Advisors Inc now owns 377 shares of the business services provider's stock valued at $25,000 after purchasing an additional 305 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. bought a new stake in shares of Exponent during the 2nd quarter valued at $26,000. Allworth Financial LP raised its position in shares of Exponent by 86.1% during the 4th quarter. Allworth Financial LP now owns 469 shares of the business services provider's stock valued at $33,000 after purchasing an additional 217 shares during the period. Public Employees Retirement System of Ohio purchased a new position in shares of Exponent during the 2nd quarter valued at $29,000. Finally, Bessemer Group Inc. lifted its stake in shares of Exponent by 37.1% during the 1st quarter. Bessemer Group Inc. now owns 717 shares of the business services provider's stock valued at $47,000 after buying an additional 194 shares in the last quarter. 92.37% of the stock is owned by hedge funds and other institutional investors.

Exponent Company Profile

(Get Free Report)

Exponent, Inc NASDAQ: EXPO is an engineering and scientific consulting firm that offers multidisciplinary analysis and advisory services to clients across a range of industries. The company's expertise spans mechanical, materials and corrosion engineering, civil and structural engineering, electrical engineering, industrial hygiene, toxicology and health sciences, and failure analysis. Exponent provides support for product design, performance evaluation, litigation consulting, and regulatory compliance, helping manufacturers, insurers, law firms and government agencies address complex technical challenges.

Founded in 1967 in Menlo Park, California, Exponent has grown from a small failure-analysis laboratory into a global consulting practice.

Recommended Stories

Insider Buying and Selling by Quarter for Exponent (NASDAQ:EXPO)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Exponent Right Now?

Before you consider Exponent, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.

While Exponent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines